Reynolds Thomas H, Dalton Allison, Calzini Lucas, Tuluca Andrei, Hoyte Dakembay, Ives Stephen J
Department of Health and Human Physiological Sciences, Skidmore College, Saratoga Springs, New York.
Physiol Rep. 2019 Feb;7(3):e13995. doi: 10.14814/phy2.13995.
A paucity of data exists regarding sex differences in age-related obesity and insulin resistance, particularly in the preclinical murine model. The purpose of this study was to determine the effects of age and sex on insulin action and body composition in C57BL/6J mice. Aged (AG, 18 months old) male C57BL/6J mice, glucose tolerance was diminished compared to young (YG, 6 months old) male mice (Area Under Curve: 95,103 ± 6818 vs. 64,005 ± 2031, P = 0.002). However, there was no age-related decline in glucose or insulin tolerance in females. Body composition analysis revealed that AG males had significantly greater body mass (42.2 ± 1.9 vs. 30.0 ± 0.4 g, P < 0.0001), fat mass (18.7 ± 2.0 vs. 3.3 ± 0.4 g, P < 0.0001), body fat (43.0 ± 3.0 vs. 11.0 ± 1.5%, P < 0.0001) than YG males. In AG females, body mass (32.8 ± 1.6 vs. 26.3 ± 0.9 g, P = 0.02) was higher, but fat mass (13.3 ± 2.0 vs. 9.5 ± 1.3 g, P = 0.24) and body fat (37.8 ± 4.8 vs. 35.5 ± 3.8%, P = 0.67) were similar when compared to YG females. AG males had significantly higher body mass (42.2 ± 1.9 vs. 32.8 ± 1.6 g, P = 0.001) and fat mass (18.7 ± 2.0 vs. 13.3 ± 2.0 g, P = 0.04) compared to AG females; however, body fat (43.0 ± 3.0 vs. 37.8 ± 4.8%, P = 0.28) was similar. Six weeks of treatment with MitoQ, a mitochondrial-targeted antioxidant, did not reverse age-related obesity in male mice. Surprisingly, obesity and insulin resistance appear to be reversed in the oldest of the old male mice (28 vs. 20 months). Our findings indicate that female mice, unlike males, are protected from age-related obesity and insulin resistance.
关于年龄相关性肥胖和胰岛素抵抗中的性别差异,尤其是在临床前小鼠模型中的数据较少。本研究的目的是确定年龄和性别对C57BL/6J小鼠胰岛素作用和身体组成的影响。老年(AG,18个月大)雄性C57BL/6J小鼠的葡萄糖耐量与年轻(YG,6个月大)雄性小鼠相比有所降低(曲线下面积:95,103±6818 vs. 64,005±2031,P = 0.002)。然而,雌性小鼠中未观察到与年龄相关的葡萄糖或胰岛素耐量下降。身体组成分析显示,AG雄性小鼠的体重(42.2±1.9 vs. 30.0±0.4 g,P < 0.0001)、脂肪量(18.7±2.0 vs. 3.3±0.4 g,P < 0.0001)、体脂率(43.0±3.0 vs. 11.0±1.5%,P < 0.0001)均显著高于YG雄性小鼠。在AG雌性小鼠中,体重(32.8±1.6 vs. 26.3±0.9 g,P = 0.02)较高,但与YG雌性小鼠相比,脂肪量(13.3±2.0 vs. 9.5±1.3 g,P = 0.24)和体脂率(37.8±4.8 vs. 35.5±3.8%,P = 0.67)相似。与AG雌性小鼠相比,AG雄性小鼠的体重(42.2±1.9 vs. 32.8±1.6 g,P = 0.001)和脂肪量(18.7±2.0 vs. 13.3±2.0 g,P = 0.04)显著更高;然而,体脂率(43.0±3.0 vs. 37.8±4.8%,P = 0.28)相似。用线粒体靶向抗氧化剂MitoQ治疗六周并未逆转雄性小鼠与年龄相关的肥胖。令人惊讶的是,最老的老年雄性小鼠(28个月与20个月)的肥胖和胰岛素抵抗似乎得到了逆转。我们的研究结果表明,与雄性小鼠不同,雌性小鼠可免受年龄相关性肥胖和胰岛素抵抗的影响。